These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis. Gaillard JL; Cahen P; Delacourt C; Silly C; Le Bourgeois M; Coustère C; de Blic J; Lenoir G; Scheinmann P Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):291-6. PubMed ID: 7649191 [TBL] [Abstract][Full Text] [Related]
7. Comparison of piperacillin vs. ticarcillin plus tobramycin in the treatment of acute pulmonary exacerbations of cystic fibrosis. Jackson MA; Kusmiesz H; Shelton S; Prestidge C; Kramer RI; Nelson JD Pediatr Infect Dis; 1986; 5(4):440-3. PubMed ID: 3725655 [TBL] [Abstract][Full Text] [Related]
8. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2008 Jul; (3):CD006961. PubMed ID: 18646176 [TBL] [Abstract][Full Text] [Related]
9. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. Ryan G; Jahnke N; Remmington T Cochrane Database Syst Rev; 2012 Dec; 12():CD008319. PubMed ID: 23235659 [TBL] [Abstract][Full Text] [Related]
10. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Banerjee D; Stableforth D Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122 [TBL] [Abstract][Full Text] [Related]
11. The role of piperacillin therapy in pulmonary exacerbations of cystic fibrosis: a controlled study. Macfarlane PI; Hughes DM; Landau LI; Olinsky A Pediatr Pulmonol; 1985; 1(5):249-55. PubMed ID: 3906545 [TBL] [Abstract][Full Text] [Related]
12. Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis. Prince AS; Neu HC J Pediatr; 1980 Jul; 97(1):148-51. PubMed ID: 6445961 [No Abstract] [Full Text] [Related]
13. [Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis]. Prévotat A; Leroy S; Perez T; Wallet F; Wallaert B Rev Mal Respir; 2010 May; 27(5):449-56. PubMed ID: 20569877 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of β-lactams as single agents for treating severe pulmonary exacerbations during pregnancy in cystic fibrosis. Prickett M; Jain M Am J Respir Crit Care Med; 2012 Dec; 186(12):1310-1. PubMed ID: 23250504 [No Abstract] [Full Text] [Related]
15. Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin. Parry MF; Neu HC; Merlino M; Gaerlan PF; Ores CN; Denning CR J Pediatr; 1977 Jan; 90(1):144-8. PubMed ID: 401521 [TBL] [Abstract][Full Text] [Related]
16. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution? Nichols L; Maki DG Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938 [TBL] [Abstract][Full Text] [Related]
17. Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients. Cantón R; Máiz L; Escribano A; Olveira C; Oliver A; Asensio O; Gartner S; Roma E; Quintana-Gallego E; Salcedo A; Girón R; Barrio MI; Pastor MD; Prados C; Martínez-Martínez MT; Barberán J; Castón JJ; Martínez-Martínez L; Poveda JL; Vázquez C; de Gracia J; Solé A; Arch Bronconeumol; 2015 Mar; 51(3):140-50. PubMed ID: 25614377 [TBL] [Abstract][Full Text] [Related]
18. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277 [TBL] [Abstract][Full Text] [Related]
19. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. Elphick HE; Tan A Cochrane Database Syst Rev; 2001; (1):CD002007. PubMed ID: 11279745 [TBL] [Abstract][Full Text] [Related]